The construction of a cluster of superior specialties of traditional Chinese medicine in Qilu is a reform task determined by the Provincial Party Committee and the provincial government in 2020. It aims to use three years to innovate the cluster construction model through leading specialties, and strive to build a specialized echelon with obvious provincial advantages, county-led leadership, and reasonable regional distribution.As the leading specialty, the Department of Oncology of Yantai Hospital of Traditional Chinese Medicine, in accordance with the work deployment requirements of the Provincial Health Commission, is committed to leading its member specialties to build a cluster of provincial demonstration and leading, inter-provincial regional radiation, and influential specialties across the country, and establish a brand of traditional Chinese medicine specialties with Shandong characteristics with excellent clinical efficacy, obvious characteristics and advantages, outstanding innovation capabilities, strong comprehensive strength, and strong radiation drive, so that the level of diagnosis and treatment of the dominant diseases of traditional Chinese medicine has reached the domestic or international leading level.
Recently, the first group of the oncology Department of the Qilu Superior Specialty Cluster of Traditional Chinese Medicine conducted an online consultation and consultation seminar on difficult cases. The meeting was initiated by the lead unit, Vice President Hou Aixiu of Yantai Hospital of Traditional Chinese Medicine. Experts such as Yu Chunfeng, Dai Lingling, Mu Yuejun, Deputy Chief Physician, Zhou Jiajing, deputy Chief Physician, etc. Participated in the online exchange. The member unit Weihai Hospital of Traditional Chinese Medicine Jiang Chunxiang, Chief Physician of Haiyang Hospital of Traditional Chinese Medicine Sun Nianjun, Chief Physician of Haiyang Hospital of Traditional Chinese Medicine, and the backbone specialist participated in the meeting. More than 20 people attended the meeting.

First of all, the Department of Oncology of Weihai Hospital of Traditional Chinese Medicine provided a case of elderly bladder cancer. The patient has experienced multiple relapses and multiple surgical treatments. At present, there are extensive liver metastases, abdominal and retroperitoneal metastases, multiple bone metastases, and cervical lymph node metastases.In view of the follow-up treatment issues, the experts at the meeting conducted in-depth analysis and discussions on the latest research progress, diagnosis and treatment norms, and characteristic traditional Chinese medicine therapies at home and abroad.Experts agree that precision diagnosis and treatment based on genetic testing and multidisciplinary cooperative diagnosis and treatment are the basic principles of follow-up treatment.From the perspective of traditional Chinese medicine, this disease belongs to the categories of “hemolysis”, “drowning” and “confinement”, and the basic pathogenesis is positive deficiency and evil prosperity.Kidney qi deficiency and bladder dampness and heat are the key to its pathogenesis. It is advisable to nourish kidney qi, clear heat and dampness, reduce stasis, detoxify and stop bleeding. Astragalus, cinnamon combined with poria soup, Bazhengsan or Xiaojiyinzi can be used for addition and subtraction treatment.

Subsequently, the Department of Oncology of Haiyang Hospital of Traditional Chinese Medicine reported a case of advanced colorectal cancer. After 2 years of combined targeted chemotherapy treatment, the patient is making progress again.Based on the specific circumstances of the patients, the participating experts conducted in-depth discussions on chemotherapy, targeted therapy, immunotherapy, prevention and treatment of adverse drug reactions, and personalized treatment experience.From the perspective of traditional Chinese medicine, the basic pathogenesis of colorectal cancer is based on false standards, irregular diet, appetite for fat and sweetness, loss of temper, weakness of movement and transformation, endogenous dampness and evil, internal and external dampness, gathering into phlegm, blocking qi, stasis for a long time, phlegm and stasis are bound to each other, staying in the intestine, metaplastic toxicity.“Spleen deficiency" runs through the onset of colorectal cancer, and it is advisable to strengthen the spleen and qi, reduce phlegm and stasis, detoxify and disperse knots.

After nearly 2 hours of discussion, the participating experts and the backbone of the specialties all said that through the discussion of difficult cases during this visit, they not only effectively solved the difficulties and doubts in clinical work, but also learned the most cutting-edge knowledge of oncology, which is very helpful to improve the level of diagnosis and treatment of Chinese and Western medicine.The tumor group 1 of the Qilu Traditional Chinese Medicine Advantage specialist Cluster has long organized various forms of exchanges and discussions through the organization of visits and consultations on difficult cases, seminars on the promotion of characteristic traditional Chinese medicine techniques, and various academic conferences. It aims to improve the level of standardized tumor diagnosis and treatment of member units and specialist members, strengthen the concept of integrated Chinese and Western medicine treatment, give full play to the characteristics and advantages of traditional Chinese medicine, so that more patients can benefit from Chinese medicine treatment.

Department introduction

The Department of Oncology of Yantai Hospital of Traditional Chinese Medicine is a national key clinical specialty, the Shandong Provincial Center for Traditional Chinese Medicine Oncology Diagnosis and Treatment, and the “leading specialty of the Oncology Cluster of the Qilu Superior Specialty Cluster of Traditional Chinese Medicine”.It is a master's training point of Shandong University of Traditional Chinese Medicine and Binzhou Medical College, with 7 master directors.At present, there are 5 national medical masters and national and provincial famous traditional Chinese medicine inheritance studios in the specialty. It is the executive director unit of the China Alliance for the Prevention and Treatment of Traditional Chinese Medicine, the Special Committee of Traditional Chinese Medicine Oncology of the Shandong Geriatrics Society, and the relying unit of the Tumor Rehabilitation Professional Committee of the Shandong Society of Traditional Chinese Medicine.Established a cooperative base for cancer diagnosis and treatment with Mexico (Yantai, China-Mexican Center for Traditional Chinese Medicine Oncology).
The specialty of traditional Chinese medicine has outstanding characteristics and has achieved outstanding results in the prevention and treatment of malignant tumors of traditional Chinese medicine and the clinical research of traditional Chinese medicine oncology.Western medicine is highly skilled, and minimally invasive diagnosis and treatment techniques such as radioactive particle implantation treatment technology, microwave ablation technology, and intervention have been widely used clinically. Puncture and biopsy of 3mm lumps can be performed.At present, more than 20 minimally invasive tumor diagnosis and treatment techniques have been carried out, the core pathogenesis of tumors and complications and more than 30 traditional Chinese medicine prescriptions have been summarized, 5 in-hospital preparations have been developed, more than 10 characteristic therapies of integrated Chinese and Western medicine have been refined, and 7 diagnosis and treatment plans for the dominant diseases of traditional Chinese medicine such as lung cancer have been formulated.
In recent years, the comprehensive service capabilities of specialized traditional Chinese medicine have rapidly improved. Breakthroughs have been made in solving professional problems such as short survival and poor quality of life of patients with advanced common malignant tumors such as lung cancer, stomach cancer, bowel cancer, and liver cancer, as well as refractory complications of tumors such as malignant thoracic ascites, cancer pain, cancer fever, and cancer-induced fatigue. In the past three years, a total of 9 patients with advanced malignant tumors have been clinically cured, all of which have achieved complete remission of imaging and endoscopic pathology or re-surgical pathology, and there are more survivors with tumors.